tiprankstipranks
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe FlyCantor Fitzgerald biotech analysts hold an analyst/industry conference call
2M ago
Arvinas and Pfizer Report Promising Cancer Study Results
Premium
Company Announcements
Arvinas and Pfizer Report Promising Cancer Study Results
2M ago
Arvinas, Pfizer announce initial Phase 1b data from TACTIVE-U sub-study
Premium
The Fly
Arvinas, Pfizer announce initial Phase 1b data from TACTIVE-U sub-study
2M ago
Arvinas price target lowered to $40 from $50 at Oppenheimer
PremiumThe FlyArvinas price target lowered to $40 from $50 at Oppenheimer
3M ago
Arvinas Reports Progress in Q3 2024 Financials and Trials
Premium
Company Announcements
Arvinas Reports Progress in Q3 2024 Financials and Trials
3M ago
Arvinas price target lowered to $40 from $50 at Oppenheimer
Premium
The Fly
Arvinas price target lowered to $40 from $50 at Oppenheimer
3M ago
Arvinas expects cash to fund requirements into 2027
PremiumThe FlyArvinas expects cash to fund requirements into 2027
6M ago
Arvinas CEO says making ‘meaningful progress’ across portfolio
Premium
The Fly
Arvinas CEO says making ‘meaningful progress’ across portfolio
6M ago
Arvinas reports Q2 EPS (49c), consensus (86c)
Premium
The Fly
Arvinas reports Q2 EPS (49c), consensus (86c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100